Mechanisms of Rhizoma Coptidis against type 2 diabetes mellitus explored by network pharmacology combined with molecular docking and experimental validation.
Mechanisms of Rhizoma Coptidis against type 2 diabetes mellitus explored by network pharmacology combined with molecular docking and experimental validation.
复制标题
DOI:
10.1038/s41598-021-00293-8
复制
发表时间:
2021-10-21
影响因子:
4.6
通讯作者:
Xu Y
中科院分区:
文献类型:
--
作者:
An W;Huang Y;Chen S;Teng T;Shi Y;Sun Z;Xu Y
This study systematically explored the underlying mechanism of Rhizoma Coptidis against type 2 diabetes mellitus (T2DM) by using network pharmacology and molecular docking and experimental validation. We retrieved and screened active compounds of Rhizoma Coptidis and corresponding T2DM-related targets across multiple databases. PPI networks of the genes were constructed using STRING, and the core targets were screened via topological analysis. GO and KEGG enrichment analyses were performed by using DAVID. Finally, molecular docking and experimental studies were performed after bioinformatic analysis for verification. There were 14 active compounds and 19 core targets of Rhizoma Coptidis-T2DM, of which quercetin was identified as the main compound and IL6, VEGFA and TNF were the most significant core targets. GO and KEGG enrichment analyses showed that Rhizoma Coptidis ameliorated T2DM by regulating multiple biological processes and pathways. Docking studies indicated that IL6, VEGFA and TNF could stably bind with all active compounds of Rhizoma Coptidis. The results of our experiments revealed that Rhizoma Coptidis could inhibit the expression of IL6 and TNFα and enhance islet cell viability. This study suggests anti-inflammatory therapeutic effects of Rhizoma Coptidis on T2DM, thereby providing a scientific basis and new insight for further research on the antidiabetic effect of Rhizoma Coptidis.
登录
查看更多内容
影响因子:
4.5
作者:
Huang, Cheng-Chin;Kuo, Chun-Ying;Huang, Chun-Fa
通讯作者:
Huang, Chun-Fa
影响因子:
14.9
作者:
The Gene Ontology Consortium
通讯作者:
The Gene Ontology Consortium
DOI:
10.1155/2014/495840
发表时间:
2014
期刊:
Evidence-based complementary and alternative medicine : eCAM
影响因子:
--
作者:
Li H;Zhao L;Zhang B;Jiang Y;Wang X;Guo Y;Liu H;Li S;Tong X
通讯作者:
Tong X
影响因子:
5.9
作者:
Li D;Jiang C;Mei G;Zhao Y;Chen L;Liu J;Tang Y;Gao C;Yao P
通讯作者:
Yao P
DOI:
10.1016/j.jpba.2020.113655
发表时间:
2021-01-05
影响因子:
3.4
作者:
Chen, Yang;Qi, Luming;Ma, Yuntong
通讯作者:
Ma, Yuntong